Literature DB >> 8719491

The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. Sandoz/CVIS Investigators.

L Miller1, J Kobashigawa, H Valantine, H Ventura, P Hauptman, J O'Donnell, J Wiedermann, A Yeung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8719491

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


× No keyword cloud information.
  4 in total

Review 1.  Update on pediatric heart transplantation. Long-term complications.

Authors:  R J Gajarski; D L Kearney; J K Price; S W Denfield
Journal:  Tex Heart Inst J       Date:  1997

Review 2.  Perspectives on cardiac allograft vasculopathy.

Authors:  J B Young
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 3.  Coronary artery vasculopathy in pediatric cardiac transplant patients: the therapeutic potential of immunomodulators.

Authors:  Biagio Pietra; Mark Boucek
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

4.  What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?

Authors:  Jon Kobashigawa
Journal:  Curr Control Trials Cardiovasc Med       Date:  2000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.